Page last updated: 2024-10-25

6-hydroxychlorzoxazone and Ovarian Neoplasms

6-hydroxychlorzoxazone has been researched along with Ovarian Neoplasms in 1 studies

6-hydroxychlorzoxazone: chlorzoxazone metabolite in humans

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research Excerpts

ExcerptRelevanceReference
"Patients with advanced stage ovarian cancer and healthy volunteers were recruited."2.90Altered cytochrome 2E1 and 3A P450-dependent drug metabolism in advanced ovarian cancer correlates to tumour-associated inflammation. ( Aboagye, EO; Clarke, S; Edwards, RJ; Lee, P; Liddle, C; Lozan-Kuehne, JP; Maslen, L; Ramaswami, R; Sharma, R; Trousil, S, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Trousil, S1
Lee, P1
Edwards, RJ1
Maslen, L1
Lozan-Kuehne, JP1
Ramaswami, R1
Aboagye, EO1
Clarke, S1
Liddle, C1
Sharma, R1

Trials

1 trial available for 6-hydroxychlorzoxazone and Ovarian Neoplasms

ArticleYear
Altered cytochrome 2E1 and 3A P450-dependent drug metabolism in advanced ovarian cancer correlates to tumour-associated inflammation.
    British journal of pharmacology, 2019, Volume: 176, Issue:18

    Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Caffeine; Chlorzoxazone; Cytochrome P-450 Enzyme

2019